iBstone AuraLink vs MDHearing Volt

The iBstone AuraLink is a mid-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.6/5 in our lab testing. At $649, it ranks #33 of 65 OTC hearing aids tested, placing it in the top 49% of its category. This behind-the-ear device demonstrates a distinctive performance profile with notable strengths in specific areas. Music streaming stands out as a clear highlight, scoring 3.6/5—a solid result that lands 1.68 points above the OTC category average. Feedback handling is excellent at 5.0/5, exceeding the already-high category average by 0.46 points. Own-voice comfort scores 2.7/5, slightly above the category average but only mixed in absolute terms. The AuraLink's limitations appear in speech clarity metrics. Speech in quiet scores 2.3/5, falling 0.47 points below the category average—a mixed result that may affect conversational understanding in calm environments. Speech in noise presents a more significant challenge at 1.0/5, which is 0.48 points below the category average and low in absolute terms. This hearing aid may appeal most to users who prioritize music listening and phone streaming over speech clarity in challenging environments. However, budget-conscious shoppers should note that alternatives like the iHear MatriX offer higher scores at lower prices. The AuraLink's strength in feedback stability and streaming audio quality represents a specific value proposition for users whose priorities align with these capabilities.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.